Team Tony provided me the gift of hope, and thanks to Team Tony, I will be able to participate in a clinical trial that could provide hope to many diagnosed with triple negative breast cancer (TNBC). Through their financial assistance in purchasing flights to participate in Cynvenio's triple negative breast cancer monitoring clinical trial, Team Tony is supporting scientific efforts to develop a unique liquid biopsy approach to tumor monitoring to quickly and accurately identify tumor genetic mutations within 27 genes known to be altered in breast cancer. Although this lab test can provide peace of mind to any type of breast cancer survivor, perhaps it has an even greater impact on those of us who have TNBC because while it is the least common type of breast cancer, it is the most deadly. We have the lowest 5 year survival rate of women diagnosed with breast cancer, and one-third of us diagnosed with TNBC will have a [...]